Allen Chaves - Feb 15, 2024 Form 4 Insider Report for Klaviyo, Inc. (KVYO)

Role
Chief Technology Officer
Signature
/s/ Landon Edmond, Attorney-in-Fact
Stock symbol
KVYO
Transactions as of
Feb 15, 2024
Transactions value $
-$273,926
Form type
4
Date filed
2/16/2024, 04:50 PM
Previous filing
Sep 20, 2023
Next filing
May 17, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KVYO Series A Common Stock Conversion of derivative security +9.22K 9.22K Feb 15, 2024 Direct F1, F2
transaction KVYO Series A Common Stock Tax liability -$274K -9.22K -100% $29.71 0 Feb 15, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KVYO Series B Common Stock Conversion of derivative security $0 -9.22K -4.04% $0.00 219K Feb 15, 2024 Series A Common Stock 9.22K Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents 9,220 shares of Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), automatically converted into Series A Common Stock, par value $0.001 per share ("Series A Common Stock") and subsequently withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs").
F2 Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock of the Issuer, and will automatically convert into Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date.
F3 Amount consists of (a) 83,464 shares of Series B Common Stock and (b) 135,282 unvested RSUs awarded under the 2015 Stock Incentive Plan, each representing the contingent right to receive one share of Series B Common Stock upon vesting and settlement.